Skip to Content
Get 14 Days Free
Sign Up
Sign In
Sign In
Learn
Start Investing
Investing Classroom
Investing Glossary
Plan
Tax Planning
Personal Finance
Save for College
Save for Retirement
Invest in Retirement
Research
Mutual Funds
Stocks
ETFs
Bonds
Best Investments
Portfolio
Markets
Investing
Learn
Start Investing
Investing Classroom
Investing Glossary
Plan
Tax Planning
Personal Finance
Save for College
Save for Retirement
Invest in Retirement
Research
Mutual Funds
Stocks
ETFs
Bonds
Best Investments
Portfolio
Markets
For Professionals
Research & Insights
Morningstar Blog
Featured Reports
Morningstar Magazine
The Investor Success Project
Morningstar Investment Conference
ESG Investing
Licensed Research
Software & Data Services
Morningstar Direct
Morningstar Office Cloud
Morningstar Advisor Workstation
Morningstar Data
PitchBook
Morningstar Enterprise Components
Money Management
Morningstar Retirement Manager
Morningstar Managed Portfolios
Morningstar Indexes
All Products & Services
Company
Who We Are
Work Here
Newsroom
Investor Relations
Global Contacts
Immunogen Inc
IMGN
Morningstar Rating
Rating as of
Dec 11, 2019
Quote
Stock Analysis
News
Price vs Fair Value
Trailing Returns
Financials
Valuation
Operating Performance
Dividends
Ownership
Executive
Related
US Videos
ClearBridge Fund Prepared for Extended Rally
The broad stock runup in the first half of 2013 was a boon to ClearBridge Aggressive Growth, and comanager Evan Bauman says that the fund is well-positioned for the market going forward.
Fund Spy
How Will Health-Care Reform Impact These Funds?
Some great funds see attractive opportunities in the health-care sector.
ETF Specialist
Get Instant Biotech Diversification
Using an ETF to invest in biotechs makes a ton of sense.
Stock Analyst Update
New Morningstar Stock Analyst Reports: 08/24/01
New updated reports on Walt Disney, Alcide, and more.
Stock Analyst Update
Morningstar on the Market: Week through 08/04/00
A look at which stocks are hot, and which are not.
Sponsor Center
